Back HIV/AIDS

HIV / AIDS

Latest San Francisco Annual Report Shows Drop in New HIV Infections and Deaths

Newly diagnosed HIV infections and deaths among people living with HIV in San Francisco reached new lows in 2014, and the city continues to do a better job helping people get people tested and treated than the nation as a whole. But some notable disparities persist with regard to race, age, gender identity, and homelessness, according to the SF Department of Public Health's latest HIV Epidemiology Annual Report.

alt

PROUD PrEP Study Results Published in The Lancet

The results of the PROUD study of HIV pre-exposure prophylaxis (PrEP) using daily tenofovir plus emtricitabine (Truvada) have now been published online in The Lancet scientific journal. PROUD, along with the other European randomized study of PrEP, Ipergay, demonstrated considerably higher levels of PrEP effectiveness in preventing HIV infections than any previous study. PrEP should now be offered routinely as part of sexual health services, says an accompanying editorial.

alt

Older People with HIV Have Reduced Life Expectancy

Mortality among HIV-positive people age 50 or older has fallen dramatically since the advent of effective combination antiretroviral therapy (ART) in the mid-1990s, but even well-treated people in this age group without AIDS-defining events or comorbidities have reduced survival time, on average, compared with the general population, according to a report in the August 27 advance edition of the Journal of Acquired Immune Deficiency Syndromes.

alt

U.S. PrEP Care Cascade Suggests Structural Barriers Must Be Addressed

The uptake of pre-exposure prophylaxis (PrEP) among people who need it risks being limited due to low levels of awareness, gaps in health insurance, opaque bureaucratic procedures, under-usage of medical services, and limited awareness and skills among healthcare providers, according to an analysis published online ahead of print in Clinical Infectious DiseasesAlso taking into account suboptimal adherence among some PrEP users, the researchers concluded that just 15% of gay men in Atlanta who could benefit are likely to achieve protection from HIV with PrEP.

alt

U.S. Conference on AIDS Underway this Week in D.C.

The U.S. Conference on AIDS (USCA 2015), sponsored by the National Minority AIDS Council,is taking place this week, September 10-13, in Washington, D.C. The largest U.S. conference focused on the community-based response to HIV/AIDS, USCA brings together leaders of community organizations, care providers, public health workers, advocates, government policymakers, and people living with HIV.

alt

September 18 is National HIV/AIDS and Aging Awareness Day

Friday, September 18, is the 8th annual observance of National HIV/AIDS and Aging Awareness Day (NHAAAD), an opportunity to focus on the challenges facing the aging population regarding HIV prevention, testing, care, and treatment, as well as the health and well-being of the growing population of older people living with HIV.

alt

IAS 2015: Bone Loss Slows, but Continues Long-term in HIV-positive People on Antiretroviral Therapy

People with HIV experienced a decrease in bone density at the hip and spine during their first 2 years after starting antiretroviral therapy (ART). While bone loss slowed after 96 weeks, it continued to decline more rapidly among HIV-positive people compared with the usual age-related bone loss seen in HIV-negative people over 7 years, researchers reported at the recent 8th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention in Vancouver.

alt